Adar1-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "JWN",
  "MRUS",
  "AKRO",
  "KNSA",
  "ASND",
  "EWTX",
  "CNTA",
  "NKTR",
  "INSM",
  "RVMD",
  "TIL",
  "ARGX",
  "AQN",
  "EXAS",
  "MDGL",
  "APLS",
  "ARWR",
  "PTCT",
  null,
  null,
  null,
  "IROH",
  null,
  null,
  null,
  null,
  null,
  null,
  "ABVX",
  null,
  "DVAX",
  "MREO",
  "RGNX",
  "RXRX",
  "SWTX",
  "RCKT",
  "ARVN",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TSHA",
  "ACHV",
  "NRIX",
  "STOK",
  "SMMT",
  "TECX",
  "MLYS",
  "KYMR",
  "PHAT",
  "NMRA",
  "KROS",
  "ADGM",
  "ABOS",
  "NGNE",
  "SAGE",
  "ALEC",
  "ALDX",
  "AVTX",
  "AMLX",
  "JANX",
  "AVR",
  "BIOA",
  "PHGE",
  "BOLT",
  "CLRB",
  null,
  null,
  "CTNM",
  "ESTA",
  "GERN",
  "SRRK",
  "FULC",
  "SYRE",
  "APGE",
  "ISRG",
  "ABUS",
  null,
  null,
  "KALA",
  "KRRO",
  "KALV",
  "LPTX",
  "LXEO",
  null,
  "MNPR",
  "NXTC",
  "OABI",
  "OVID",
  "OKUR",
  "RLYB",
  "PRQR",
  "QNCX",
  "PMVP",
  "RNXT",
  "SPRO",
  "SEPN",
  "STTK",
  "SGRY",
  "IOVA",
  null,
  null,
  null,
  null,
  "IKT",
  "TARA",
  "RZLT",
  "NVS",
  "TEVA",
  null,
  "ZYME",
  "ZURA",
  null,
  null,
  "OGN",
  "PFE",
  null,
  null,
  null,
  "REGN",
  null,
  null,
  "UPB",
  "RAPT",
  "PTGX",
  "PEPG",
  "AGIO",
  "AVXL",
  null,
  "SLDB",
  "TENX",
  "LYRA",
  "RYTM",
  "MLTX",
  "SLNO",
  "ACLX",
  null,
  "ETNB",
  "DYN",
  "ARDX",
  "CKPT",
  "SPRB",
  "TXMD",
  "GOSS",
  "SRPT",
  "NTRA",
  "WVE",
  "ROIV",
  null,
  null,
  "CNTB",
  "CNTX",
  "CDTX",
  "ELDN",
  "DCTH",
  null,
  "IMNM",
  "ITOS",
  "INZY",
  "KURA",
  "KZR",
  null,
  "VRNA",
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VRDN",
  "VYNE",
  "VYGR",
  "XENE",
  "XLO",
  "ZLAB",
  "XNCR",
  "ORKA",
  "BIIB",
  "BHVN",
  null,
  "IMVT",
  null,
  "PCVX",
  "BCRX",
  "BNTX",
  "BMRN",
  "BBIO",
  "CRGX",
  "CLDX",
  "CGON",
  "CLOV",
  "CRNX",
  "DAWN",
  "CTMX",
  "CYTK",
  "DNLI",
  "DNTH",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 198
Total Value: 523731625
Accession Number: 0001940272-25-000003
Form Type: 13F-HR
CIK: adar1-capital-management
Manager Name: Adar1-Capital-Management

Data Enrichment

82% identified

163 identified35 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

198 positions • $523.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 5 of 10

Sort by:

Arcellx, Inc.

ACLX|03940C100

Shares:14.0K

Value:$915.9K

% of Portfolio:0.2% ($915.9K/$523.7M)

REGENERON PHARMACEUTICALS, INC.

REGN|75886F107

Shares:1.4K

Value:$863.2K

% of Portfolio:0.2% ($863.2K/$523.7M)

G52443101

Shares:75.0K

Value:$841.5K

% of Portfolio:0.2% ($841.5K/$523.7M)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

Shares:27.9K

Value:$817.5K

% of Portfolio:0.2% ($817.5K/$523.7M)

00439U104

Shares:343.5K

Value:$783.2K

% of Portfolio:0.1% ($783.2K/$523.7M)

Kezar Life Sciences, Inc.

KZR|49372L209

Shares:147.4K

Value:$719.3K

% of Portfolio:0.1% ($719.3K/$523.7M)

ARROWHEAD PHARMACEUTICALS, INC.

ARWR|04280A100

Shares:56.3K

Value:$717.3K

% of Portfolio:0.1% ($717.3K/$523.7M)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:15.0K

Value:$662.0K

% of Portfolio:0.1% ($662.0K/$523.7M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:35.6K

Value:$616.6K

% of Portfolio:0.1% ($616.6K/$523.7M)

BIOGEN INC.

BIIB|09062X103

Shares:4.5K

Value:$615.8K

% of Portfolio:0.1% ($615.8K/$523.7M)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:101.1K

Value:$603.5K

% of Portfolio:0.1% ($603.5K/$523.7M)

Natera, Inc.

NTRA|632307104

Shares:4.3K

Value:$601.0K

% of Portfolio:0.1% ($601.0K/$523.7M)

Zymeworks Inc.

ZYME|98985Y108

Shares:50.0K

Value:$595.5K

% of Portfolio:0.1% ($595.5K/$523.7M)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:170.4K

Value:$591.5K

% of Portfolio:0.1% ($591.5K/$523.7M)

49721T507

Shares:194.7K

Value:$585.9K

% of Portfolio:0.1% ($585.9K/$523.7M)

Spero Therapeutics, Inc.

SPRO|84833T103

Shares:801.3K

Value:$576.9K

% of Portfolio:0.1% ($576.9K/$523.7M)

Biohaven Ltd.

BHVN|G1110E107

Shares:22.6K

Value:$544.3K

% of Portfolio:0.1% ($544.3K/$523.7M)

Protara Therapeutics, Inc.

TARA|74365U107

Shares:122.7K

Value:$522.7K

% of Portfolio:0.1% ($522.7K/$523.7M)

97717Y527

Shares:10.0K

Value:$503.3K

% of Portfolio:0.1% ($503.3K/$523.7M)

G0131Y100

Shares:47.1K

Value:$502.1K

% of Portfolio:0.1% ($502.1K/$523.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Arcellx, Inc.(ACLXcusip03940C100)	14.0K	QoQ +252.39% (+10.0K) YoY NEW(+14.0K)	All Managers (Combined)	$915.9K	0.2% ($915.9K/$523.7M)	QoQ +201.43% (+$612.1K) YoY NEW(+$915.9K)
REGENERON PHARMACEUTICALS, INC.(REGNcusip75886F107)	1.4K	QoQ 0.00% (-0) YoY -40.82% (-939)	All Managers (Combined)	$863.2K	0.2% ($863.2K/$523.7M)	QoQ -10.96% (-$106.3K) YoY -61.00% (-$1.4M)
(cusipG52443101)✕	75.0K	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$841.5K	0.2% ($841.5K/$523.7M)	QoQ +2.09% (+$17.3K) YoY +6.75% (+$53.3K)
AGIOS PHARMACEUTICALS, INC.(AGIOcusip00847X104)	27.9K	QoQ NEW(+27.9K) YoY NEW(+27.9K)	All Managers (Combined)	$817.5K	0.2% ($817.5K/$523.7M)	QoQ NEW(+$817.5K) YoY NEW(+$817.5K)
(cusip00439U104)✕	343.5K	QoQ -55.59% (-430.1K) YoY NEW(+343.5K)	All Managers (Combined)	$783.2K	0.1% ($783.2K/$523.7M)	QoQ -72.93% (-$2.1M) YoY NEW(+$783.2K)
Kezar Life Sciences, Inc.(KZRcusip49372L209)	147.4K	QoQ 0.00% (-0) YoY NEW(+147.4K)	All Managers (Combined)	$719.3K	0.1% ($719.3K/$523.7M)	QoQ -27.38% (-$271.2K) YoY NEW(+$719.3K)
ARROWHEAD PHARMACEUTICALS, INC.(ARWRcusip04280A100)	56.3K	QoQ +336.43% (+43.4K) YoY +9283.33% (+55.7K)	All Managers (Combined)	$717.3K	0.1% ($717.3K/$523.7M)	QoQ +195.75% (+$474.7K) YoY +4079.84% (+$700.1K)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	15.0K	QoQ NEW(+15.0K) YoY NEW(+15.0K)	All Managers (Combined)	$662.0K	0.1% ($662.0K/$523.7M)	QoQ NEW(+$662.0K) YoY NEW(+$662.0K)
Structure Therapeutics Inc.(GPCRcusip86366E106)	35.6K	QoQ +0.84% (-300) YoY +4352.37% (+34.8K)	All Managers (Combined)	$616.6K	0.1% ($616.6K/$523.7M)	QoQ -35.63% (-$341.3K) YoY +1698.19% (+$582.3K)
BIOGEN INC.(BIIBcusip09062X103)	4.5K	QoQ +47.78% (+1.5K) YoY NEW(+4.5K)	All Managers (Combined)	$615.8K	0.1% ($615.8K/$523.7M)	QoQ +32.24% (+$150.1K) YoY NEW(+$615.8K)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	101.1K	QoQ -23.17% (-30.5K) YoY NEW(+101.1K)	All Managers (Combined)	$603.5K	0.1% ($603.5K/$523.7M)	QoQ -40.28% (-$407.1K) YoY NEW(+$603.5K)
Natera, Inc.(NTRAcusip632307104)	4.3K	QoQ NEW(+4.3K) YoY NEW(+4.3K)	All Managers (Combined)	$601.0K	0.1% ($601.0K/$523.7M)	QoQ NEW(+$601.0K) YoY NEW(+$601.0K)
Zymeworks Inc.(ZYMEcusip98985Y108)	50.0K	QoQ NEW(+50.0K) YoY +2531.57% (+48.1K)	All Managers (Combined)	$595.5K	0.1% ($595.5K/$523.7M)	QoQ NEW(+$595.5K) YoY +2879.28% (+$575.5K)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	170.4K	QoQ +0.55% (-943) YoY NEW(+170.4K)	All Managers (Combined)	$591.5K	0.1% ($591.5K/$523.7M)	QoQ -46.97% (-$523.9K) YoY NEW(+$591.5K)
(cusip49721T507)✕	194.7K	QoQ -2.77% (-5.6K) YoY NEW(+194.7K)	All Managers (Combined)	$585.9K	0.1% ($585.9K/$523.7M)	QoQ -11.31% (-$74.8K) YoY NEW(+$585.9K)
Spero Therapeutics, Inc.(SPROcusip84833T103)	801.3K	QoQ 0.00% (-0) YoY -13.55% (-125.7K)	All Managers (Combined)	$576.9K	0.1% ($576.9K/$523.7M)	QoQ -30.09% (-$248.4K) YoY -63.81% (-$1.0M)
Biohaven Ltd.(BHVNcusipG1110E107)	22.6K	QoQ NEW(+22.6K) YoY +1032.05% (+20.6K)	All Managers (Combined)	$544.3K	0.1% ($544.3K/$523.7M)	QoQ NEW(+$544.3K) YoY +397.61% (+$434.9K)
Protara Therapeutics, Inc.(TARAcusip74365U107)	122.7K	QoQ 0.00% (-0) YoY +6034.50% (+120.7K)	All Managers (Combined)	$522.7K	0.1% ($522.7K/$523.7M)	QoQ -19.31% (-$125.1K) YoY +6416.94% (+$514.6K)
(cusip97717Y527)✕	10.0K	QoQ 0.00% (+0) YoY -81.13% (-43.0K)	All Managers (Combined)	$503.3K	0.1% ($503.3K/$523.7M)	QoQ +0.01% (+$100) YoY -81.11% (-$2.2M)
(cusipG0131Y100)✕	47.1K	QoQ -41.43% (-33.3K) YoY NEW(+47.1K)	All Managers (Combined)	$502.1K	0.1% ($502.1K/$523.7M)	QoQ -40.44% (-$340.9K) YoY NEW(+$502.1K)